Development of colored hydroalcoholic solutions of chlorhexidine for surgical field antisepsis: preparation process, antimicrobial and coloring efficiencies and stability study

S. Filali , L.M. Tall, E. Diouf, D. Salmon, C. Pivot, F. Pirot Pharmacie, Hôpital Édouard Herriot, Lyon, France

Background

Guidelines for the prevention of surgical site infection issued by the French Society of Hygiene Hospital [1] and World Health Organization [2] are recently in favor of a use of the chlorhexidine hydroalcoholic (CHX-OH) solution. The objective of the study was to develop new colored CHX-OH solution enabling skin staining mandatory for efficient pre-operative antisepsis.

Methods

The stability of CHX-OH solution supplemented with various dyes (sunset yellow, eosin, erythrosin) was examined immediately after mixing ingredients in order to detect the absence of sedimentation, flocculation or discoloration. The most stable colored CHX-OH solution was stored at 25°C ± 2°C, 60% ± 5% RH and 40°C ± 2°C, 75% ± 5% RH for 24 months. Pharmaceutical control, in accordance with Good Preparation Practices and European Pharmacopoeia, included the organoleptic characteristics, the dosage of the active ingredients and a microbiological control. The determinations of in vitro antiseptic efficacy according to AFNOR standards (NF EN 1040, NF EN 1275), and the efficacy of the in vivo coloring properties on white and black skin by using a colorimetric skin probe have completed this study.

Results

The tests demonstrated a better stability of CHX-OH (0.5 to 2.5% (w/v)) and eosin (0.02 to 0.05% (w/v)) solutions. All controls were satisfactory over 24 months at 25°C and up to 6 months at 40°C, but due to a random potential instability, the expiry date was fixed preferentially at 18 months. The antiseptic activity of this solution complied with AFNOR standards. Colorimetric measurements have shown that eosin had the most intense staining property, visible on white and black skin.

Discussion - Conclusion

CHX-OH and eosin solution, having many clinical and technical advantages, has been upgraded by an international patent WO2017021667 (A1) [3].

References

[1Société française d’hygiène hospitalière. Antisepsie de la peau saine avant un geste invasif chez l’adulte Recommandations pour la pratique Clinique, 2016

[2World Health Organization. Global guidelines for the prevention of surgical site infection, 2016

[3Solutions hydroalcooliques colorées de chlorhexidine, leurs procédés de fabrication et leurs utilisations. S. Filali, F. Pirot, L. Tall, C. Pivot. Dépôt de brevet WO2017021667 (A1), FR3039768 (A1), 2015-08-06

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data